JP | JPY
-
-
-
- Challenges and Chances: A Review of the 1st Stem Cell Community Day
- Summertime, and the Livin’ Is Easy…
- Follow-on-Biologics – More than Simple Generics
- Bacteria Versus Body Cells: A 1:1 Tie
- Behind the Crime Scene: How Biological Traces Can Help to Convict Offenders
- Every 3 Seconds Someone in the World Is Affected by Alzheimer's
- HIV – It’s Still Not Under Control…
- How Many Will Be Convicted This Time?
- Malaria – the Battle is Not Lost
- Physicians on Standby: The Annual Flu Season Can Be Serious
- At the Forefront in Fighting Cancer
- Molecular Motors: Think Small and yet Smaller Again…
- Liquid Biopsy: Novel Methods May Ease Cancer Detection and Therapy
- They Are Invisible, Sneaky and Disgusting – But Today It’s Their Special Day!
- How Many Cells Are in Your Body? Probably More Than You Think!
- What You Need to Know about Antibiotic Resistance – Findings, Facts and Good Intentions
- Why Do Old Men Have Big Ears?
- The Condemned Live Longer: A Potential Paradigm Shift in Genetics
- From Research to Commerce
- Chronobiology – How the Cold Seasons Influence Our Biorhythms
- Taskforce Microbots: Targeted Treatment from Inside the Body
- Eyes on Cancer Therapy
-
-
-
-
-
- Challenges and Chances: A Review of the 1st Stem Cell Community Day
- Summertime, and the Livin’ Is Easy…
- Follow-on-Biologics – More than Simple Generics
- Bacteria Versus Body Cells: A 1:1 Tie
- Behind the Crime Scene: How Biological Traces Can Help to Convict Offenders
- Every 3 Seconds Someone in the World Is Affected by Alzheimer's
- HIV – It’s Still Not Under Control…
- How Many Will Be Convicted This Time?
- Malaria – the Battle is Not Lost
- Physicians on Standby: The Annual Flu Season Can Be Serious
- At the Forefront in Fighting Cancer
- Molecular Motors: Think Small and yet Smaller Again…
- Liquid Biopsy: Novel Methods May Ease Cancer Detection and Therapy
- They Are Invisible, Sneaky and Disgusting – But Today It’s Their Special Day!
- How Many Cells Are in Your Body? Probably More Than You Think!
- What You Need to Know about Antibiotic Resistance – Findings, Facts and Good Intentions
- Why Do Old Men Have Big Ears?
- The Condemned Live Longer: A Potential Paradigm Shift in Genetics
- From Research to Commerce
- Chronobiology – How the Cold Seasons Influence Our Biorhythms
- Taskforce Microbots: Targeted Treatment from Inside the Body
- Eyes on Cancer Therapy
-
-
JP | JPY
GMP info
Regarding suitability of Eppendorf bioprocess equipment in GMP-regulated applications, please reach out to your Eppendorf sales representative.
Yeast Fermentation
Advantages of yeast fermentation in the biopharmaceutical industry
What is yeast fermentation? When thinking of yeast fermentation in bioprocessing, food, ethanol and biofuel production may come to mind. However, yeast is a versatile microorganism that is also widely used in the biopharmaceutical industry, for the expression of recombinant proteins to prevent or treat diseases. Industry-relevant yeast species include Saccharomyces cerevisiae and Pichia pastoris.
Yeast fermentation is well suited for the large-scale production of therapeutic proteins, due to:
Microorganisms including and yeast are ideal for large-scale bioprocessing due to their high yields and fast growth. However, an advantage of yeast cells in particular is that they are eukaryotic and so they are more comparable to human cells. Consequently, yeast cells can perform a range of post-translational protein modifications that bacteria are unable to. These modifications are essential for the functioning of therapeutic proteins and include glycosylation, protein folding and phosphorylation.
Yeast fermentation is well suited for the large-scale production of therapeutic proteins, due to:
- Fast growth rate
- Easy genetic manipulation
- High cell productivity
- Ability to be grown at high cell densities
- High tolerance to deviations in pH and temperature (compared to mammalian cells)
- Cheaper costs and shorter cultivation cycles than mammalian cell cultures
Microorganisms including and yeast are ideal for large-scale bioprocessing due to their high yields and fast growth. However, an advantage of yeast cells in particular is that they are eukaryotic and so they are more comparable to human cells. Consequently, yeast cells can perform a range of post-translational protein modifications that bacteria are unable to. These modifications are essential for the functioning of therapeutic proteins and include glycosylation, protein folding and phosphorylation.
もっと読む
表示を減らす
What properties make a bioreactor system suitable for microbial production?
Find out, which bioreactor features can support achieving high cell densities, simplify scale-up, and streamline bioprocess optimization.
もっと読む
表示を減らす
Pichia pastoris fermentation: Basic information
Pichia pastoris is a popular species for yeast fermentation in the large-scale production of recombinant proteins. This yeast species is capable of achieving high cell densities and protein yields, and is also easy to scale up, demonstrating high levels of reproducibility in small-scale, through to bench-scale and production-scale bioprocesses. In shakers or bioreactors of any size, Pichia pastoris can be used as a powerful protein expression system.
もっと読む
表示を減らす
Optimizing protein expression in yeast fermentation
Developing a commercially viable yeast fermentation process requires the optimization product yields. An adequate supply of nutrients must be ensured, to support high cell densities. The promoter system is another important factor that determines protein expression. Here we will have a look at some factors that can contribute to the optimization of protein expression in yeast.
もっと読む
表示を減らす
Methanol-free induction of protein expression in Pichia pastoris
For protein expression in Pichia pastoris, traditionally, the AOX1 promoter is used that requires the presence of methanol for its activation. Concerns of methanol have been raised due to its toxicity and flammability, resulting in a need to move away from the use of methanol in yeast fermentation.To overcome this, other Pichia pastoris promoters such as PUPP can function in the presence of other carbon sources including glycercol. These promoters have enabled the development of safer methanol-free Pichia pastoris expression systems. Learn how to set up methanol-free Pichia pastoris bioprocessing systems!
もっと読む
表示を減らす
Choosing between batch, fed-batch, and continuous fermentation
The operation mode of a yeast culture relates to the strategy of feed addition, and is an important consideration for yields and productivity. Read more how choosing between fatch fermentation, fed-batch fermentation and continuous culture can be used to optimize your bioprocess.
もっと読む
表示を減らす
Bioreactor systems for yeast fermentation from 60 mL to 2,400 L
Eppendorf bioreactor systems demonstrate robust and scalable fermentation across several applications, including the use of Pichia pastoris cultures for biologics production.
- Scalability from 60 mL to 2,400 L
- Used in combination with BioBLU® f Single-Use Bioreactors , glass bioreactors, or sterilize-in-place bioreactors
- Comprehensive bioprocess monitoring and control through DASware® control and BioCommand® bioprocess control software